ClinicalTrials.govpublic full text
Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer
ovarian cancer, chemotherapy-free regimen, niraparib, bevacizumab, dostarlimab, recurrent ovarian cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 856277
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.